DGX Message Board - Msg: 13433199

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DGX

DGX 178.85

+1.6%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Smartypts who wrote (1)	4/15/2000 9:48:00 AM
From: Smartypts	Read Replies (1) of 32

TETERBORO, N.J., April 14 (Reuters) - Quest Diagnostics Inc. (NYSE: DGX) said Friday that it expects first-quarter earnings to be about 50 percent above analysts' estimates of $0.24 per share and 2000 year earnings to be about 20 percent above estimates of $1.47 per share. The company, which conducts clinical laboratory tests for other drug firms, did not give specific figures for its earnings expectations, which are before one-time items. Quest was not immediately available to clarify the special items. Quest said the growth in earnings reflects better than anticipated clinical testing volume, improved revenue per order and accelerated realization of net synergies associated with its acquisition of SmithKline Beecham Clinical Laboratories last year. Quest said it expects to issue its first quarter 2000 financial results after the close of the stock market on April 24. Shares of Quest were up 1-5/16 at 44.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next